THE IFRS FINANCIAL RESULTS INLCUDED IN EXHIBIT 99.1 AND THE TEXT OF EXHIBITS 99.2 AND 99.3 OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT’S REGISTRATION STATEMENTS ON FORM F-3 (NOS. 333-199696 AND 333-144171) AND FORM S-8 (NOS. 333-187533, 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
-
|
|
|
|
-
|
|
-
|
EX-101.INS
|
-
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
EX-101.SCH
|
-
|
Inline XBRL Taxonomy Extension Schema Document
|
EX-101.CAL
|
-
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
EX-101.DEF
|
-
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
EX-101.LAB
|
-
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
EX-101.PRE
|
-
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
-
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
|
|
Ellomay Capital Ltd.
By: /s/ Ran Fridrich
Ran Fridrich
Chief Executive Officer and Director
|
• |
Revenues were approximately €25.5 million for the six months ended June 30, 2023, compared to approximately €29.2 million for the six months
ended June 30, 2022. This decrease mainly results from the decrease in electricity prices in Spain and from a curtailment of the electricity supply from the Company’s facilities to the grid during June 2023 due to maintenance and upgrade
work on the main transmission line between Spain and Portugal, which caused a decrease in revenues of approximately €1 million. The Company subsequently implemented a solution aimed at minimizing the impact of future similar curtailments.
The decrease in revenues was partially offset by an increase in revenues from the Company’s biogas plants in the Netherlands, resulting mainly from increased production and an increase in the 2023 gas price, and from the connection to the
grid of Ellomay Solar (a 28 MW photovoltaic plant in Spain) during June 2022, upon which the Company commenced recognition of revenues.
|
• |
Operating expenses were approximately €12 million for the six months ended June 30, 2023, compared to approximately €13.1 million for the six months ended June 30, 2022. The decrease in operating expenses mainly results from a decrease in
payments under the Spanish RDL 17/2022, caused by a reduction in the electricity market price. RDL 17/2022 established the reduction of returns on the electricity generating activity of Spanish production facilities that do not emit
greenhouse gases, accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. As a result of the decrease in the electricity market price in Spain during the first half of 2023, the
payments under RDL 17/2022 were lower during this period compared to the same period last year. This decrease in operating expenses was partially offset by increased operating expenses in connection with the Company’s biogas operations in the
Netherlands caused by the use of higher quality raw materials due to lower availability of cheaper raw materials, and from the connection to the grid of Ellomay Solar during June 2022, upon which the Company commenced recognition of expenses.
Depreciation expenses were approximately €8.1 million for the six months ended June 30, 2023, compared to approximately €8 million for the six months ended June 30, 2022.
|
• |
Project development costs were approximately €2.2 million for the six months ended June 30, 2023, compared to approximately €1.6 million for the six months ended June 30, 2022. The increase in project development costs is mainly due to the
increase in development activities in connection with photovoltaic projects in Israel and USA.
|
• |
General and administrative expenses were approximately €2.9 million for the six months ended June 30, 2023, compared to approximately €3.3 million for the six months ended June 30, 2022. The decrease in general and administrative expenses
is mostly due to a decrease in D&O liability insurance costs and bonuses paid to employees in 2022.
|
• |
Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €1.5 million for the six months ended June 30, 2023, compared to share of loss of equity accounted investee of approximately
€0.6 million for the six months ended June 30, 2022. The increase in share of profits of equity accounted investee was mainly due to the increase in revenues of Dorad Energy Ltd. (“Dorad”) due to higher
quantities produced and a higher electricity tariff in Israel, partially offset by an increase in operating expenses in connection with the increased production and higher tariff.
|
• |
Financing income, net was approximately €1.6 million for the six months ended June 30, 2023, compared to financing expenses, net of approximately €2.2 million for the six months ended June 30, 2022. The change was mainly attributable to
income resulting from exchange rate differences amounting to approximately €6.9 million in the six months ended June 30, 2023, mainly in connection with the New Israeli Shekel (“NIS”) cash and cash
equivalents and the Company’s NIS denominated debentures, compared to income in the amount of approximately €2.6 million for the six months ended June 30, 2022, caused by the 7.1% appreciation of the euro against the NIS during the six months
ended June 30, 2023, compared to the 3.3% appreciation of the euro against the NIS during the six months ended June 30, 2022.
|
• |
Tax benefit was approximately €1.2 million for the six months ended June 30, 2023, compared to taxes on income of approximately €1.1 million for the six months ended June 30, 2022.
|
• |
Profit for the six months ended June 30, 2023, was approximately €4.6 million, compared to a loss of approximately €0.6 million for the six months ended June 30, 2022.
|
• |
Total other comprehensive income was approximately €31.1 million for the six months ended June 30, 2023, compared to total other comprehensive loss of approximately €34.8 million for the six months ended June 30, 2022. The change mainly
resulted from changes in fair value of cash flow hedges, including a material increase in the fair value of the financial power swap (the “Talasol PPA”) that
covers approximately 80% of the output of the Talasol PV Plant compared to the same period last year. The Talasol PPA experienced a high volatility due to the significant changes in electricity prices in Europe that included a substantial
increase in prices during 2021 and 2022 and a substantial decrease in prices during 2023. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a
hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows. As the Company controls Talasol, the total impact of the
changes in fair value of the Talasol PPA (including the minority share) is consolidated into the Company’s financial statements and total equity.
|
• |
Total comprehensive income was approximately €35.7 million for the six months ended June 30, 2023, compared to total comprehensive loss of approximately €35.4 million for the six months ended June 30, 2022.
|
• |
EBITDA was approximately €9.9 million for the six months ended June 30, 2023, compared to approximately €10.6 million for the six months ended June 30, 2022. See the table on page 14 of this press release for a reconciliation of these
numbers to profit and loss.
|
• |
Net cash provided by operating activities was approximately €5.3 million for the six months ended June 30, 2023, compared to approximately €8 million for the six months ended June 30, 2022. The decrease in net cash provided by operating
activities for the six months ended June 30, 2023, is mainly due to the decrease in electricity prices in Spain.
|
- |
Construction of New Projects: solar projects in Italy and a pumped hydro storage project in the Manara Cliff in Israel.
|
- |
Initiating and Developing of New Projects: solar projects in Italy, Spain, USA and Israel.
|
- |
Management, Operation and Improvement of Generating Projects: in Israel (PV), Spain (PV) and the Netherlands (bio-gas).
|
1. |
The Komemiyut Project: intended for 21 MW PV and 47 MW / hour batteries. The project has an approval for connection to the grid and is in the process of receiving a building permit. Commencement of construction is planned
for the first quarter of 2024.
|
2. |
The Qelahim Project: intended for 15 MW PV and 33 MW / hour batteries. The project has an approval for connection to the grid, and is in the final stages of the zoning approval.
|
3. |
The Talmei Yosef Project: an expansion of the existing project to 104 dunams, intended for 10 MW PV and 22 MW / hour batteries. The request for zoning approval has been filed and approval is expected to be received in the
fourth quarter of 2023.
|
4. |
The Talmei Yosef Storage Project in Batteries: there is a zoning approval for 30 dunam, intended for approximately 400 MW / hour. The project is designed for the regulation of high voltage storage.
|
5. |
The Sharsheret Project: intended for 20 MW PV and 44 MW / hour batteries. The zoning request was submitted.
|
6. |
In addition, the Company has approximately 250 dunams under advanced planning stages.
|
• |
Approximately 35.9 MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
|
• |
9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel’s total
current electricity consumption;
|
• |
51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
|
• |
Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3
million, 3.8 million and 9.5 million Nm3 per year, respectively;
|
• |
83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
|
• |
Ellomay Solar Italy One SRL and Ellomay Solar Italy Two SRL that are constructing photovoltaic plants with installed capacity of 14.8 MW and 4.95 MW, respectively, in the Lazio Region, Italy;
|
• |
Ellomay Solar Italy Four SRL, Ellomay Solar Italy Five SRL, Ellomay Solar Italy Seven SRL, Ellomay Solar Italy Nine SRL and Ellomay Solar Italy Ten SRL that are developing photovoltaic projects with installed
capacity of 15.06 MW, 87.2 MW, 54.77 MW, 8 MW and 18 MW, respectively, in Italy that have reached “ready to build” status; and
|
• |
Fairfield Solar Project, LLC, Malakoff Solar I, LLC, Malakoff Solar II, LLC, that are developing photovoltaic projects with installed capacity of 13 MW, 6.5 MW and 6.5 MW, respectively, in the Dallas
Metropolitan area, Texas, and have reached “ready to build” status.
|
June 30,
|
December 31,
|
June 30,
|
||||||||||
2023
|
2022
|
2023
|
||||||||||
€ in thousands
|
Convenience Translation into US$ in thousands*
|
|||||||||||
Assets
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
73,870
|
46,458
|
80,229
|
|||||||||
Marketable securities
|
-
|
2,836
|
-
|
|||||||||
Short term deposits
|
1,007
|
-
|
1,094
|
|||||||||
Restricted cash
|
810
|
900
|
880
|
|||||||||
Receivable from concession project
|
1,638
|
1,799
|
1,779
|
|||||||||
Intangible asset from green certificates
|
1,723
|
585
|
1,871
|
|||||||||
Trade and other receivables
|
14,404
|
12,097
|
15,644
|
|||||||||
93,452
|
64,675
|
101,497
|
||||||||||
Non-current assets
|
||||||||||||
Investment in equity accounted investee
|
29,345
|
30,029
|
31,871
|
|||||||||
Advances on account of investments
|
3,105
|
2,328
|
3,372
|
|||||||||
Receivable from concession project
|
22,468
|
24,795
|
24,402
|
|||||||||
Fixed assets
|
380,849
|
365,756
|
413,633
|
|||||||||
Right-of-use asset
|
30,603
|
30,020
|
33,237
|
|||||||||
Intangible asset
|
3,650
|
4,094
|
3,964
|
|||||||||
Restricted cash and deposits
|
19,018
|
20,192
|
20,655
|
|||||||||
Deferred tax
|
11,613
|
23,510
|
12,613
|
|||||||||
Long term receivables
|
9,279
|
9,270
|
10,078
|
|||||||||
Derivatives
|
1,221
|
1,488
|
1,326
|
|||||||||
511,151
|
511,482
|
555,151
|
||||||||||
Total assets
|
604,603
|
576,157
|
656,648
|
|||||||||
Liabilities and Equity
|
||||||||||||
Current liabilities
|
||||||||||||
Current maturities of long-term bank loans
|
12,020
|
12,815
|
13,055
|
|||||||||
Current maturities of long-term loans
|
5,000
|
10,000
|
5,430
|
|||||||||
Current maturities of debentures
|
35,635
|
18,714
|
38,702
|
|||||||||
Trade payables
|
3,319
|
4,504
|
3,605
|
|||||||||
Other payables
|
15,531
|
11,207
|
16,868
|
|||||||||
Current maturities of derivatives
|
8,309
|
33,183
|
9,024
|
|||||||||
Current maturities of lease liabilities
|
775
|
745
|
842
|
|||||||||
80,589
|
91,168
|
87,526
|
||||||||||
Non-current liabilities
|
||||||||||||
Long-term lease liabilities
|
22,943
|
22,005
|
24,918
|
|||||||||
Long-term loans
|
242,364
|
229,466
|
263,227
|
|||||||||
Other long-term bank loans
|
27,915
|
21,582
|
30,318
|
|||||||||
Debentures
|
103,943
|
91,714
|
112,891
|
|||||||||
Deferred tax
|
6,069
|
6,770
|
6,591
|
|||||||||
Other long-term liabilities
|
1,377
|
2,021
|
1,496
|
|||||||||
Derivatives
|
563
|
28,354
|
611
|
|||||||||
405,174
|
401,912
|
440,052
|
||||||||||
Total liabilities
|
485,763
|
493,080
|
527,578
|
|||||||||
Equity
|
||||||||||||
Share capital
|
25,613
|
25,613
|
27,818
|
|||||||||
Share premium
|
86,100
|
86,038
|
93,512
|
|||||||||
Treasury shares
|
(1,736
|
)
|
(1,736
|
)
|
(1,885
|
)
|
||||||
Transaction reserve with non-controlling Interests
|
5,697
|
5,697
|
6,187
|
|||||||||
Reserves
|
(577
|
)
|
(12,632
|
)
|
(627
|
)
|
||||||
Accumulated deficit
|
(1,780
|
)
|
(7,256
|
)
|
(1,933
|
)
|
||||||
Total equity attributed to shareholders of the Company
|
113,317
|
95,724
|
123,072
|
|||||||||
Non-Controlling Interest
|
5,523
|
(12,647
|
)
|
5,998
|
||||||||
Total equity
|
118,840
|
83,077
|
129,070
|
|||||||||
Total liabilities and equity
|
604,603
|
576,157
|
656,648
|
For the Three months ended
June 30,
|
For the Six months ended
June 30,
|
For the year ended December 31,
|
For the six months ended June 30,
|
|||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
2022
|
2023
|
|||||||||||||||||||
€ in thousands
|
€ in thousands
|
€ in thousands
|
Convenience Translation into US$ in thousands**
|
|||||||||||||||||||||
Revenues
|
13,430
|
17,435
|
25,458
|
29,196
|
53,360
|
27,649
|
||||||||||||||||||
Operating expenses
|
(5,576
|
)
|
(7,161
|
)
|
(12,028
|
)
|
(13,132
|
)
|
(24,089
|
)
|
(13,063
|
)
|
||||||||||||
Depreciation and amortization expenses
|
(3,949
|
)
|
(3,964
|
)
|
(8,064
|
)
|
(7,978
|
)
|
(16,092
|
)
|
(8,758
|
)
|
||||||||||||
Gross profit
|
3,905
|
6,310
|
5,366
|
8,086
|
13,179
|
5,828
|
||||||||||||||||||
Project development costs
|
(1,028
|
)
|
(843
|
)
|
(2,192
|
)
|
(1,554
|
)
|
(3,784
|
)
|
(2,381
|
)
|
||||||||||||
General and administrative expenses
|
(1,431
|
)
|
(1,820
|
)
|
(2,911
|
)
|
(3,297
|
)
|
(5,892
|
)
|
(3,162
|
)
|
||||||||||||
Share of profits (losses) of equity accounted investee
|
363
|
(833
|
)
|
1,541
|
(602
|
)
|
1,206
|
1,674
|
||||||||||||||||
Operating profit
|
1,809
|
2,814
|
1,804
|
2,633
|
4,709
|
1,959
|
||||||||||||||||||
Financing income
|
3,618
|
3,630
|
9,021
|
4,439
|
9,565
|
9,798
|
||||||||||||||||||
Financing income (expenses) in connection with derivatives and warrants, net
|
(562
|
)
|
372
|
(476
|
)
|
338
|
605
|
(517
|
)
|
|||||||||||||||
Financing expenses in connection with projects finance
|
(1,897
|
)
|
(2,524
|
)
|
(3,782
|
)
|
(3,889
|
)
|
(7,765
|
)
|
(4,108
|
)
|
||||||||||||
Financing expenses in connection with debentures
|
(1,012
|
)
|
(314
|
)
|
(1,840
|
)
|
(1,343
|
)
|
(2,130
|
)
|
(1,998
|
)
|
||||||||||||
Interest expenses on minority shareholder loan
|
(468
|
)
|
(349
|
)
|
(933
|
)
|
(892
|
)
|
(1,529
|
)
|
(1,013
|
)
|
||||||||||||
Other financing expenses
|
(146
|
)
|
(50
|
)
|
(434
|
)
|
(834
|
)
|
(1,212
|
)
|
(471
|
)
|
||||||||||||
Financing income (expenses), net
|
(467
|
)
|
765
|
1,556
|
(2,181
|
)
|
(2,466
|
)
|
1,691
|
|||||||||||||||
Profit before taxes on income
|
1,342
|
3,579
|
3,360
|
452
|
2,243
|
3,650
|
||||||||||||||||||
Tax benefit (Taxes on income)
|
(53
|
)
|
(808
|
)
|
1,203
|
(1,087
|
)
|
(2,103
|
)
|
1,307
|
||||||||||||||
Profit (loss) for the period
|
1,289
|
2,771
|
4,563
|
(635
|
)
|
140
|
4,957
|
|||||||||||||||||
Profit (loss) attributable to:
|
||||||||||||||||||||||||
Owners of the Company
|
1,395
|
1,712
|
5,476
|
(1,222
|
)
|
(357
|
)
|
5,947
|
||||||||||||||||
Non-controlling interests
|
(106
|
)
|
1,059
|
(913
|
)
|
587
|
497
|
(990
|
)
|
|||||||||||||||
Profit (loss) for the period
|
1,289
|
2,771
|
4,563
|
(635
|
)
|
140
|
4,957
|
|||||||||||||||||
Other comprehensive income (loss) item
|
||||||||||||||||||||||||
that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss:
|
||||||||||||||||||||||||
Foreign currency translation differences for foreign operations
|
(2,703
|
)
|
*(3,585
|
)
|
(8,253
|
)
|
*(3,683
|
)
|
*(7,829
|
)
|
(8,963
|
)
|
||||||||||||
Effective portion of change in fair value of cash flow hedges
|
9,795
|
*22,311
|
44,200
|
*(8,875
|
)
|
*8,976
|
48,004
|
|||||||||||||||||
Net change in fair value of cash flow hedges transferred to profit or loss
|
(2,578
|
)
|
*(12,673
|
)
|
(4,809
|
)
|
*(22,246
|
)
|
*(36,438
|
)
|
(5,223
|
)
|
||||||||||||
Total other comprehensive income (loss)
|
4,514
|
6,053
|
31,138
|
(34,804
|
)
|
(35,291
|
)
|
33,818
|
||||||||||||||||
Total other comprehensive income (loss) attributable to:
|
||||||||||||||||||||||||
Owners of the Company
|
1,040
|
1,618
|
12,055
|
(19,051
|
)
|
(19,920
|
)
|
13,093
|
||||||||||||||||
Non-controlling interests
|
3,474
|
4,435
|
19,083
|
(15,753
|
)
|
(15,371
|
)
|
20,725
|
||||||||||||||||
Total other comprehensive income (loss) for the period
|
4,514
|
6,053
|
31,138
|
(34,804
|
)
|
(35,291
|
)
|
33,818
|
||||||||||||||||
Total comprehensive income (loss) for the period
|
5,803
|
8,824
|
35,701
|
(35,439
|
)
|
(35,151
|
)
|
38,775
|
||||||||||||||||
Total comprehensive income (loss) attributable to:
|
||||||||||||||||||||||||
Owners of the Company
|
2,435
|
3,330
|
17,531
|
(20,273
|
)
|
(20,277
|
)
|
19,040
|
||||||||||||||||
Non-controlling interests
|
3,368
|
5,494
|
18,170
|
(15,166
|
)
|
(14,874
|
)
|
19,735
|
||||||||||||||||
Total comprehensive income (loss) for the period
|
5,803
|
8,824
|
35,701
|
(35,439
|
)
|
(35,151
|
)
|
38,775
|
||||||||||||||||
Basic net earnings (loss) per share
|
0.11
|
0.13
|
0.43
|
(0.10
|
)
|
(0.03
|
)
|
0.46
|
||||||||||||||||
Diluted net earnings (loss) per share
|
0.11
|
0.13
|
0.43
|
(0.10
|
)
|
(0.03
|
)
|
0.46
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated Deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the six months ended
|
||||||||||||||||||||||||||||||||||||||||
June 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2023
|
25,613
|
86,038
|
(7,256
|
)
|
(1,736
|
)
|
7,970
|
(20,602
|
)
|
5,697
|
95,724
|
(12,647
|
)
|
83,077
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
-
|
-
|
5,476
|
-
|
-
|
-
|
-
|
5,476
|
(913
|
)
|
4,563
|
|||||||||||||||||||||||||||||
Other comprehensive loss for the period
|
-
|
-
|
-
|
-
|
(7,882
|
)
|
19,937
|
-
|
12,055
|
19,083
|
31,138
|
|||||||||||||||||||||||||||||
Total comprehensive loss for the period
|
-
|
-
|
5,476
|
-
|
(7,882
|
)
|
19,937
|
-
|
17,531
|
18,170
|
35,701
|
|||||||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Share-based payments
|
-
|
62
|
-
|
-
|
-
|
-
|
-
|
62
|
-
|
62
|
||||||||||||||||||||||||||||||
Balance as at June 30, 2023
|
25,613
|
86,100
|
(1,780
|
)
|
(1,736
|
)
|
88
|
(665
|
)
|
5,697
|
113,317
|
5,523
|
118,840
|
|||||||||||||||||||||||||||
For the six months ended
|
||||||||||||||||||||||||||||||||||||||||
June 30, 2022:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2022
|
25,605
|
85,883
|
(6,899
|
)
|
(1,736
|
)
|
15,365
|
(8,077
|
)
|
5,697
|
115,838
|
(1,731
|
)
|
114,107
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
-
|
-
|
(1,222
|
)
|
-
|
-
|
-
|
-
|
(1,222
|
)
|
587
|
(635
|
)
|
|||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
-
|
-
|
-
|
-
|
(3,466
|
)
|
(15,585
|
)
|
-
|
(19,051
|
)
|
(15,753
|
)
|
(34,804
|
)
|
|||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
-
|
-
|
(1,222
|
)
|
-
|
(3,466
|
)
|
(15,585
|
)
|
-
|
(20,273
|
)
|
(15,166
|
)
|
(35,439
|
)
|
||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of Capital note to non-controlling interest
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3,958
|
3,958
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
60
|
-
|
-
|
-
|
-
|
-
|
60
|
-
|
60
|
||||||||||||||||||||||||||||||
Balance as at June 30, 2022
|
25,605
|
85,943
|
(8,121
|
)
|
(1,736
|
)
|
11,899
|
(23,662
|
)
|
5,697
|
95,625
|
(12,939
|
)
|
82,686
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the year ended December 31, 2022:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2022
|
25,605
|
85,883
|
(6,899
|
)
|
(1,736
|
)
|
15,365
|
(8,077
|
)
|
5,697
|
115,838
|
(1,731
|
)
|
114,107
|
||||||||||||||||||||||||||
Profit (loss) for the year
|
-
|
-
|
(357
|
)
|
-
|
-
|
-
|
-
|
(357
|
)
|
497
|
140
|
||||||||||||||||||||||||||||
Other comprehensive loss for the year
|
-
|
-
|
-
|
-
|
(7,395
|
)
|
(12,525
|
)
|
-
|
(19,920
|
)
|
(15,371
|
)
|
(35,291
|
)
|
|||||||||||||||||||||||||
Total comprehensive loss for the year
|
-
|
-
|
(357
|
)
|
-
|
(7,395
|
)
|
(12,525
|
)
|
-
|
(20,277
|
)
|
(14,874
|
)
|
(35,151
|
)
|
||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of Capital note to non-controlling interest
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3,958
|
3,958
|
||||||||||||||||||||||||||||||
Options exercise
|
8
|
28
|
-
|
-
|
-
|
-
|
-
|
36
|
-
|
36
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
127
|
-
|
-
|
-
|
-
|
-
|
127
|
-
|
127
|
||||||||||||||||||||||||||||||
Balance as at December 31, 2022
|
25,613
|
86,038
|
(7,256
|
)
|
(1,736
|
)
|
7,970
|
(20,602
|
)
|
5,697
|
95,724
|
(12,647
|
)
|
83,077
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Retained earnings
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
Convenience translation into US$ (exchange rate as at June 30, 2023: euro 1 = US$ 1.086)
|
||||||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2023
|
27,818
|
93,445
|
(7,880
|
)
|
(1,885
|
)
|
8,655
|
(22,375
|
)
|
6,187
|
103,965
|
(13,737
|
)
|
90,228
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
-
|
-
|
5,947
|
-
|
-
|
-
|
-
|
5,947
|
(990
|
)
|
4,957
|
|||||||||||||||||||||||||||||
Other comprehensive loss for the period
|
-
|
-
|
-
|
-
|
(8,560
|
)
|
21,653
|
-
|
13,093
|
20,725
|
33,818
|
|||||||||||||||||||||||||||||
Total comprehensive loss for the period
|
-
|
-
|
5,947
|
-
|
(8,560
|
)
|
21,653
|
-
|
19,040
|
19,735
|
38,775
|
|||||||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Share-based payments
|
-
|
67
|
-
|
-
|
-
|
-
|
-
|
67
|
-
|
67
|
||||||||||||||||||||||||||||||
Balance as at June 30, 2023
|
27,818
|
93,512
|
(1,933
|
)
|
(1,885
|
)
|
95
|
(722
|
)
|
6,187
|
123,072
|
5,998
|
129,070
|
For the three months ended
June 30,
|
For the six months ended
June 30,
|
For the year ended December 31,
|
For the six months ended June 30
|
|||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
2022
|
2023
|
|||||||||||||||||||
€ in thousands
|
Convenience Translation into US$*
|
|||||||||||||||||||||||
Cash flows from operating activities
|
||||||||||||||||||||||||
Profit (loss) for the period
|
1,289
|
2,771
|
4,563
|
(635
|
)
|
140
|
4,957
|
|||||||||||||||||
Adjustments for:
|
||||||||||||||||||||||||
Financing expenses, net
|
467
|
(765
|
)
|
(1,556
|
)
|
2,181
|
2,466
|
(1,691
|
)
|
|||||||||||||||
Depreciation and amortization
|
3,949
|
3,964
|
8,064
|
7,978
|
16,092
|
8,758
|
||||||||||||||||||
Share-based payment transactions
|
31
|
60
|
62
|
60
|
127
|
67
|
||||||||||||||||||
Share of losses (profits) of equity accounted investees
|
(363
|
)
|
833
|
(1,541
|
)
|
602
|
(1,206
|
)
|
(1,674
|
)
|
||||||||||||||
Change in trade receivables and other receivables
|
1,931
|
235
|
558
|
(2,579
|
)
|
724
|
606
|
|||||||||||||||||
Change in other assets
|
(35
|
)
|
(1,788
|
)
|
(155
|
)
|
53
|
(209
|
)
|
(168
|
)
|
|||||||||||||
Change in receivables from concessions project
|
579
|
(802
|
)
|
836
|
(550
|
)
|
(521
|
)
|
908
|
|||||||||||||||
Change in trade payables
|
(533
|
)
|
(726
|
)
|
(1,409
|
)
|
(801
|
)
|
1,697
|
(1,530
|
)
|
|||||||||||||
Change in other payables
|
(1,034
|
)
|
2,604
|
383
|
7,878
|
3,807
|
416
|
|||||||||||||||||
Income tax expense (tax benefit)
|
53
|
808
|
(1,203
|
)
|
1,087
|
2,103
|
(1,307
|
)
|
||||||||||||||||
Income taxes paid
|
(20
|
)
|
(3,255
|
)
|
(20
|
)
|
(3,255
|
)
|
(6,337
|
)
|
(22
|
)
|
||||||||||||
Interest received
|
860
|
451
|
1,353
|
922
|
1,896
|
1,469
|
||||||||||||||||||
Interest paid
|
(3,741
|
)
|
(4,520
|
)
|
(4,664
|
)
|
(4,924
|
)
|
(9,459
|
)
|
(5,065
|
)
|
||||||||||||
Net cash provided by (used in) operating activities
|
3,433
|
(130
|
)
|
5,271
|
8,017
|
11,320
|
5,724
|
|||||||||||||||||
Cash flows from investing activities
|
||||||||||||||||||||||||
Acquisition of fixed assets
|
(14,137
|
)
|
(6,747
|
)
|
(27,468
|
)
|
(22,274
|
)
|
(48,610
|
)
|
(29,832
|
)
|
||||||||||||
VAT associated with the acquisition
|
-
|
2,225
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Repayment of loan by an equity accounted investee
|
-
|
149
|
-
|
149
|
149
|
-
|
||||||||||||||||||
Loan to an equity accounted investee
|
(8
|
)
|
-
|
(68
|
)
|
-
|
(128
|
)
|
(74
|
)
|
||||||||||||||
Advances on account of investments
|
(395
|
)
|
-
|
(777
|
)
|
-
|
(774
|
)
|
(844
|
)
|
||||||||||||||
Settlement of derivatives contract
|
-
|
-
|
-
|
(528
|
)
|
(528
|
)
|
-
|
||||||||||||||||
Proceeds from (investment in) in restricted cash, net
|
-
|
(9,344
|
)
|
893
|
(8,241
|
)
|
(4,873
|
)
|
970
|
|||||||||||||||
Proceeds from (investment in) in short term deposit
|
20,688
|
27,645
|
(1,257
|
)
|
27,645
|
27,645
|
(1,365
|
)
|
||||||||||||||||
Proceeds from (investment in) marketable securities
|
-
|
-
|
2,837
|
-
|
(1,062
|
)
|
3,081
|
|||||||||||||||||
Net cash provided by (used in) investing activities
|
6,148
|
13,928
|
(25,840
|
)
|
(3,249
|
)
|
(28,181
|
)
|
(28,064
|
)
|
||||||||||||||
Cash flows from financing activities
|
||||||||||||||||||||||||
Proceeds from options
|
-
|
-
|
-
|
-
|
36
|
-
|
||||||||||||||||||
Cost associated with long term loans
|
(391
|
)
|
(498
|
)
|
(706
|
)
|
(8,958
|
)
|
(9,988
|
)
|
(767
|
)
|
||||||||||||
Payment of principal of lease liabilities
|
(577
|
)
|
(205
|
)
|
(777
|
)
|
(4,000
|
)
|
(5,703
|
)
|
(844
|
)
|
||||||||||||
Proceeds from long term loans
|
20,735
|
-
|
21,499
|
196,189
|
215,170
|
23,350
|
||||||||||||||||||
Repayment of long-term loans
|
(5,916
|
)
|
(22,054
|
)
|
(6,602
|
)
|
(143,095
|
)
|
(153,751
|
)
|
(7,170
|
)
|
||||||||||||
Repayment of Debentures
|
(17,763
|
)
|
(19,764
|
)
|
(17,763
|
)
|
(19,764
|
)
|
(19,764
|
)
|
(19,292
|
)
|
||||||||||||
Repayment of SWAP instrument associated with long term loans
|
-
|
-
|
-
|
(3,290
|
)
|
(3,290
|
)
|
-
|
||||||||||||||||
Proceeds from issuance of Debentures, net
|
-
|
-
|
55,808
|
-
|
-
|
60,612
|
||||||||||||||||||
Proceeds from settlement of derivatives, net
|
-
|
-
|
-
|
-
|
3,800
|
-
|
||||||||||||||||||
Net cash provided by (used in) financing activities
|
(3,912
|
)
|
(42,521
|
)
|
51,459
|
17,082
|
26,510
|
55,889
|
||||||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents
|
(1,536
|
)
|
(2,307
|
)
|
(3,478
|
)
|
(3,128
|
)
|
(4,420
|
)
|
(3,777
|
)
|
||||||||||||
Increase (decrease) in cash and cash equivalents
|
4,133
|
(31,030
|
)
|
27,412
|
18,722
|
5,229
|
29,772
|
|||||||||||||||||
Cash and cash equivalents at the beginning of the period
|
69,737
|
90,981
|
46,458
|
41,229
|
41,229
|
50,457
|
||||||||||||||||||
Cash and cash equivalents at the end of the period
|
73,870
|
59,951
|
73,870
|
59,951
|
46,458
|
80,229
|
PV
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||||
Ellomay
|
Bio
|
reportable
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||
Italy
|
Spain
|
Solar
|
Talasol
|
USA
|
Israel
|
Gas
|
Dorad
|
Manara
|
segments
|
Reconciliations
|
consolidated
|
|||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2023
|
||||||||||||||||||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||||||||||
Revenues
|
-
|
1,463
|
2,080
|
12,666
|
-
|
459
|
8,790
|
30,305
|
-
|
55,763
|
(30,305
|
)
|
25,458
|
|||||||||||||||||||||||||||||||||||
Operating expenses
|
-
|
(264
|
)
|
(882
|
)
|
(3,125
|
)
|
-
|
(183
|
)
|
(7,574
|
)
|
(22,588
|
)
|
-
|
(34,616
|
)
|
22,588
|
(12,028
|
)
|
||||||||||||||||||||||||||||
Depreciation expenses
|
(1
|
)
|
(458
|
)
|
(469
|
)
|
(5,684
|
)
|
-
|
(236
|
)
|
(1,204
|
)
|
(2,871
|
)
|
-
|
(10,923
|
)
|
2,859
|
(8,064
|
)
|
|||||||||||||||||||||||||||
Gross profit (loss)
|
(1
|
)
|
741
|
729
|
3,857
|
-
|
40
|
12
|
4,846
|
-
|
10,224
|
(4,858
|
)
|
5,366
|
||||||||||||||||||||||||||||||||||
Adjusted Gross profit (loss)
|
(1
|
)
|
741
|
729
|
3,857
|
-
|
678
|
2
|
12
|
4,846
|
-
|
10,862
|
(5,496
|
)
|
5,366
|
|||||||||||||||||||||||||||||||||
Project development costs
|
(2,192
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
General and administrative expenses
|
(2,911
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Share of loss of equity accounted investee
|
1,541
|
|||||||||||||||||||||||||||||||||||||||||||||||
Operating profit
|
1,804
|
|||||||||||||||||||||||||||||||||||||||||||||||
Financing income
|
9,021
|
|||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection with derivatives and warrants, net
|
(476
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection with projects finance
|
(3,782
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection with debentures
|
(1,840
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Interest expenses on minority shareholder loan
|
(933
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Other financing expenses
|
(434
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses, net
|
1,556
|
|||||||||||||||||||||||||||||||||||||||||||||||
Income before taxes on Income
|
3,360
|
|||||||||||||||||||||||||||||||||||||||||||||||
Segment assets as at June 30, 2023
|
33,932
|
13,806
|
19,635
|
230,428
|
1,091
|
31,635
|
31,910
|
99,033
|
155,245
|
616,715
|
(12,112
|
)
|
604,603
|
For the three months ended
June 30,
|
For the six months ended
June 30,
|
For the year ended December 31,
|
For the six months ended June 30,
|
|||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
2022
|
2023
|
|||||||||||||||||||
€ in thousands
|
Convenience Translation into US$ in thousands*
|
|||||||||||||||||||||||
Net profit (loss) for the period
|
1,289
|
2,771
|
4,563
|
(635
|
)
|
140
|
4,957
|
|||||||||||||||||
Financing (income) expenses, net
|
467
|
(765
|
)
|
(1,556
|
)
|
2,181
|
2,466
|
(1,691
|
)
|
|||||||||||||||
Taxes on income (Tax benefit)
|
53
|
808
|
(1,203
|
)
|
1,087
|
2,103
|
(1,307
|
)
|
||||||||||||||||
Depreciation
|
3,949
|
3,964
|
8,064
|
7,978
|
16,092
|
8,758
|
||||||||||||||||||
EBITDA
|
5,758
|
6,778
|
9,868
|
10,611
|
20,801
|
10,717
|
For the four-quarter period ended June 30, 2023
|
||||
Unaudited
|
||||
€ in thousands
|
||||
Profit for the period
|
5,338
|
|||
Financing expenses, net
|
(1,271
|
)
|
||
Taxes on income
|
(187
|
)
|
||
Depreciation
|
16,178
|
|||
Share-based payments
|
129
|
|||
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
|
2,366
|
|||
Adjusted EBITDA as defined the Series C Deed of Trust
|
22,553
|
For the four-quarter period ended June 30, 2023
|
||||
Unaudited
|
||||
€ in thousands
|
||||
Profit for the period
|
5,338
|
|||
Financing expenses, net
|
(1,271
|
)
|
||
Taxes on income
|
(187
|
)
|
||
Depreciation and amortization expenses
|
16,178
|
|||
Share-based payments
|
129
|
|||
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
|
2,366
|
|||
Adjusted EBITDA as defined the Series D Deed of Trust
|
22,553
|
For the four-quarter period ended June 30, 2023
|
||||
Unaudited
|
||||
€ in thousands
|
||||
Profit for the period
|
5,338
|
|||
Financing expenses, net
|
(1,271
|
)
|
||
Taxes on income
|
(187
|
)
|
||
Depreciation and amortization expenses
|
16,178
|
|||
Share-based payments
|
129
|
|||
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
|
2,366
|
|||
Adjusted EBITDA as defined the Series E Deed of Trust
|
22,553
|
Ellomay Capital Ltd. and its Subsidiaries Unaudited Condensed Consolidated Interim Financial Statements As at June 30, 2023 |
Page | |
F-3 | |
F-4 | |
F-5-F-8 | |
F-9 | |
F-10 |
June 30,
|
December 31,
|
June 30,
|
||||||||||||||
2023
|
2022
|
2023
|
||||||||||||||
Convenience Translation
|
||||||||||||||||
Note
|
€ in thousands
|
into US$ in thousands*
|
||||||||||||||
Assets
|
||||||||||||||||
Current assets
|
||||||||||||||||
Cash and cash equivalents
|
|
|
|
|||||||||||||
Marketable securities
|
4
|
|
|
|
||||||||||||
Short term deposits
|
4
|
|
|
|
||||||||||||
Restricted cash
|
4
|
|
|
|
||||||||||||
Receivable from concession project
|
|
|
|
|||||||||||||
Intangible asset from green certificates
|
|
|
|
|||||||||||||
Trade and other receivables
|
5
|
|
|
|
||||||||||||
|
|
|
||||||||||||||
Non-current assets
|
||||||||||||||||
Investment in equity accounted investee
|
6
|
|
|
|
||||||||||||
Advances on account of investments
|
|
|
|
|||||||||||||
Receivable from concession project
|
|
|
|
|||||||||||||
Fixed assets
|
8
|
|
|
|
||||||||||||
Right-of-use asset
|
10 |
|
|
|
||||||||||||
Intangible asset
|
|
|
|
|||||||||||||
Restricted cash and deposits
|
4
|
|
|
|
||||||||||||
Deferred tax
|
|
|
|
|||||||||||||
Long term receivables
|
5
|
|
|
|
||||||||||||
Derivatives
|
7
|
|
|
|
||||||||||||
|
|
|
||||||||||||||
Total assets
|
|
|
|
|||||||||||||
Liabilities and Equity
|
||||||||||||||||
Current liabilities
|
||||||||||||||||
Current maturities of long-term bank loans
|
|
|
|
|||||||||||||
Current maturities of other long-term loans
|
|
|
|
|||||||||||||
Current maturities of debentures
|
|
|
|
|||||||||||||
Trade payables
|
|
|
|
|||||||||||||
Other payables
|
|
|
|
|||||||||||||
Current maturities of derivatives
|
7 |
|
|
|
||||||||||||
Current maturities of lease liabilities
|
|
|
|
|||||||||||||
|
|
|
||||||||||||||
Non-current liabilities
|
||||||||||||||||
Long-term lease liabilities
|
10 |
|
|
|
||||||||||||
Long-term bank loans
|
|
|
|
|||||||||||||
Other long-term loans
|
|
|
|
|||||||||||||
Debentures
|
|
|
|
|||||||||||||
Deferred tax
|
|
|
|
|||||||||||||
Other long-term liabilities
|
|
|
|
|||||||||||||
Derivatives
|
7
|
|
|
|
||||||||||||
|
|
|
||||||||||||||
Total liabilities
|
|
|
|
|||||||||||||
Equity
|
||||||||||||||||
Share capital
|
|
|
|
|||||||||||||
Share premium
|
|
|
|
|||||||||||||
Treasury shares
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||
Transaction reserve with non-controlling Interests
|
|
|
|
|||||||||||||
Reserves
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||
Total equity attributed to shareholders of the Company
|
|
|
|
|||||||||||||
Non-Controlling Interest
|
|
(
|
)
|
|
||||||||||||
Total equity
|
|
|
|
|||||||||||||
Total liabilities and equity
|
|
|
|
Ellomay Capital Ltd. and its Subsidiaries
For the six
months ended
June 30,
|
For the year
ended December
|
For the six
months ended
|
||||||||||||||
2023
|
2022
|
31, 2022
|
June 30, 2023
|
|||||||||||||
Convenience
|
||||||||||||||||
Translation
|
||||||||||||||||
€ in thousands (except per share amounts)
|
into US$**
|
|||||||||||||||
Revenues
|
|
|
|
|
||||||||||||
Operating expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Depreciation and amortization expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Gross profit
|
|
|
|
|
||||||||||||
Project development costs
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
General and administrative expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Share of profits (losses) of equity accounted investee
|
|
(
|
)
|
|
|
|||||||||||
Operating profit
|
|
|
|
|
||||||||||||
Financing income
|
|
|
|
|
||||||||||||
Financing income (expenses) in connection with derivatives and warrants, net
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Financing expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Financing income (expenses), net
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Profit before taxes on income
|
|
|
|
|
||||||||||||
Tax benefit (Taxes on income)
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Profit (loss) for the period
|
|
(
|
)
|
|
|
|||||||||||
Profit (loss) attributable to:
|
||||||||||||||||
Owners of the Company
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Non-controlling interests
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Profit (loss) for the period
|
|
(
|
)
|
|
|
|||||||||||
Other comprehensive loss items that after initial recognition
|
||||||||||||||||
in comprehensive income (loss) were or will be transferred
|
||||||||||||||||
to profit or loss:
|
||||||||||||||||
Foreign currency translation differences for foreign operations
|
(
|
)
|
*(
|
)
|
*(
|
)
|
(
|
)
|
||||||||
Effective portion of change in fair value of cash flow hedges
|
|
*(
|
)
|
*
|
|
|
||||||||||
Net change in fair value of cash flow hedges transferred to profit or loss
|
( |
) |
*(
|
) |
*(
|
) |
( |
) |
||||||||
Total other comprehensive income (loss)
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Total other comprehensive income (loss) attributable to:
|
||||||||||||||||
Owners of the Company
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Non-controlling interests
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Total other comprehensive income (loss)
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Total comprehensive income (loss) for the period
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Total comprehensive income (loss) for the period attributable to:
|
||||||||||||||||
Owners of the Company
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Non-controlling interests
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Total comprehensive income (loss) for the period
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Basic net earning (loss) per share
|
|
(
|
)
|
(
|
)
|
|
||||||||||
Diluted net earning (loss) per share
|
|
(
|
)
|
(
|
)
|
|
Ellomay Capital Ltd. and its Subsidiaries
Unaudited Condensed Consolidated Interim Statements of Changes in Equity
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2023
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
|
|
|
|
|
|
|
|
( |
) |
|
|||||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Balance as at June 30, 2023
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
|
|
Ellomay Capital Ltd. and its Subsidiaries
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2022:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2022
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||||||||
Other comprehensive loss for the period
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||||||
Total comprehensive loss for the period
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of Capital note to non-controlling interest
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Balance as at June 30, 2022
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
Ellomay Capital Ltd. and its Subsidiaries
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the year ended December 31, 2022: |
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2022
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||
Profit (loss) for the year
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
||||||||||||||||||||||||||||
Other comprehensive loss for the year
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||||||
Total comprehensive loss for the year
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of Capital note to non-controlling interest |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Options exercise |
|
|
|
|||||||||||||||||||||||||||||||||||||
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Balance as at December 31, 2022
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
The accompanying notes are an integral part of the condensed consolidated interim financial statements.
Ellomay Capital Ltd. and its Subsidiaries
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Accumulated deficit
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
Convenience translation into US$*
|
||||||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2023
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||
Profit (loss) for the period
|
|
|
|
|
|
|
|
|
|
|
(
|
) |
|
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Share-based payments |
||||||||||||||||||||||||||||||||||||||||
Balance as at June 30, 2023
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated interim financial statements.
Ellomay Capital Ltd. and its Subsidiaries
For the six months ended
June 30,
|
For the year |
For the six
months ended
|
||||||||||||||
2023
|
2022
|
31, 2022
|
June 30, 2023
|
|||||||||||||
Convenience
|
||||||||||||||||
Translation
|
||||||||||||||||
€ in thousands
|
into US$*
|
|||||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Profit (loss) for the period
|
|
|
(
|
)
|
|
|
|
|
||||||||
Adjustments for:
|
||||||||||||||||
Financing income (expenses), net
|
(
|
) |
|
|
(
|
) | ||||||||||
Depreciation and amortization
|
|
|
|
|
||||||||||||
Share-based payment transactions
|
|
|
|
|
||||||||||||
Share of losses (profits) of equity accounted investees
|
(
|
) |
|
(
|
)
|
(
|
) | |||||||||
Change in trade receivables and other receivables
|
|
|
(
|
)
|
|
|
|
|
||||||||
Change in other assets
|
(
|
) |
|
|
(
|
)
|
(
|
) | ||||||||
Change in receivables from concessions project
|
|
|
(
|
) |
(
|
) |
|
|
||||||||
Change in trade payables
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
Change in other payables
|
|
|
|
|
||||||||||||
Income tax expense (tax benefit)
|
(
|
) |
|
|
|
(
|
) | |||||||||
Income taxes paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Interest received
|
|
|
|
|
||||||||||||
Interest paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net cash provided by operating activities
|
|
|
|
|
||||||||||||
Cash flows from investing activities
|
||||||||||||||||
Acquisition of fixed assets
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Repayment of loan by an equity accounted investee
|
|
|
|
|
||||||||||||
Loan to an equity accounted investee
|
(
|
) |
|
|
(
|
)
|
(
|
) | ||||||||
Advances on account of investments
|
(
|
) |
|
|
(
|
) |
(
|
) | ||||||||
Settlement of derivatives contract
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||
Proceeds from (investment in) in restricted cash, net
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||
Proceeds from (investment in) short term deposit
|
(
|
) |
|
|
|
(
|
) | |||||||||
Proceeds from (investment in) marketable securities
|
|
|
(
|
)
|
|
|||||||||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Cash flows from financing activities
|
||||||||||||||||
Proceeds from options
|
|
|
|
|
||||||||||||
Cost associated with long term loans
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Payment of principal of lease liabilities
|
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Proceeds from long term loans
|
|
|
|
|
||||||||||||
Repayment of long-term loans
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Repayment of Debentures
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Repayment of SWAP instrument associated with long term loans
|
|
|
(
|
) |
(
|
) |
|
|
||||||||
Proceed from settlement of derivatives, net
|
|
|
|
|
||||||||||||
Proceeds from issuance of Debentures, net
|
|
|
|
|
||||||||||||
Net cash provided by financing activities
|
|
|
|
|
||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents
|
(
|
)
|
(
|
) |
(
|
) |
(
|
)
|
||||||||
Increase in cash and cash equivalents
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at the beginning of the period
|
|
|
|
|
||||||||||||
Cash and cash equivalents at the end of the period
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated interim financial statements.
Ellomay Capital Ltd. and its Subsidiaries
i. |
a fixed pledge first degree on shares of Ellomay Luzon Energy Ltd. (“Ellomay Luzon Energy”) held by Ellomay Clean Energy Limited Partnership (“Ellomay Energy LP”), a limited partnership directly and indirectly wholly-owned by the Company, representing a
|
ii. |
a floating first degree pledge and an assignment by way of a pledge of, and with respect to, Ellomay Energy LP’s rights and agreements in connection with shareholder’s loans provided by Ellomay Energy LP to Ellomay Luzon Energy; and
|
iii. |
a fixed first degree pledge on the Company’s rights and the rights of Ellomay Energy LP in and to a trust bank account in the name of the trustee of the Series E Secured Debentures.
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Note 1 - General (cont’d)
a. |
The Company’s Adjusted Balance Sheet Equity (as such term is defined in the Series E Deed of Trust, which, among other exclusions, excludes changes in the fair value of hedging transactions of electricity prices, such as the
|
b. |
The ratio of (a) the short-term and long-term debt from banks, in addition to the debt to holders of debentures issued by the Company and any other interest-bearing financial obligations provided by entities who are in the business of lending money (excluding financing of projects and other exclusions as set forth in the Series E Deed of Trust), net of cash and cash equivalents, short-term investments, deposits, financial funds and negotiable securities, to the extent that these are not restricted (with the exception of a restriction for the purpose of securing any financial debt according to this definition) (hereinafter, together – the “Series E Net Financial Debt”), to (b) the Company’s
|
c. |
The ratio of (a) the Company’s Series E Net Financial Debt, to (b) the Company’s earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef project, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date occurred in the four quarters that preceded the test date will be calculated based on Annual Gross Up (as such terms are defined in the Series E Deed of Trust), based on the aggregate four preceding quarters (hereinafter – the “Series E Adjusted EBITDA”), to which the Company refer to herein as the Series E Ratio of Net Financial Debt to Series E Adjusted EBITDA, shall not be higher than 12 for three consecutive quarters for purposes of the immediate repayment provision and shall not be higher than 11 for purposes of the update of the annual interest provision.
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
€ in thousands
|
||||||||
Marketable securities (1)
|
|
|
||||||
Short-term restricted cash
|
|
|
||||||
Short-term deposits
|
|
|
||||||
Restricted cash and bank deposits, long-term (2)
|
|
|
1. |
During 2022, the Company invested in a traded Corporate Bond with a coupon rate of
|
2. |
Deposits used to secure obligations towards the Israeli Electricity Authority for the license for the pumped-storage project in the Manara Cliff in Israel and to secure obligations under loan agreements.
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
€ in thousands
|
||||||||
Current Assets:
|
||||||||
Trade and other receivables:
|
||||||||
Government authorities
|
|
|
||||||
Income receivable
|
|
|
||||||
Interest receivable
|
|
|
||||||
Advance tax payment
|
|
|
||||||
Trade receivable
|
|
|
||||||
Inventory
|
|
|
||||||
Derivatives (Note 7)
|
|
|
||||||
Prepaid expenses and other
|
|
|
||||||
Short term loan given to an equity accounted investee
|
|
|
||||||
|
|
|||||||
Non-current Assets:
|
||||||||
Long term receivables
|
||||||||
Prepaid expenses associated with long term loans
|
|
|
||||||
Annual rent deposits
|
|
|
||||||
Loans to others
|
|
|
||||||
Other
|
|
|
||||||
|
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
In connection with the description of the petition to approve a derivative claim filed by Edelcom Ltd., one of the shareholders of Dorad (“Edelcom”), included in Note 6.A to the annual financial statements, in connection with an alleged breach of the entrepreneurship agreement, the arbitration award issued on June 28, 2023 provided, inter alia, that the entrepreneurship agreement was not breached and therefore there is no basis for approving a derivative claim.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Note 6 - Investee Companies and Other Investments (cont’d)
Information about investee companies and other investments (cont’d)
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
June 30,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
€ in thousands
|
||||||||
Derivatives presented under current assets
|
||||||||
Swap contracts |
|
|
||||||
Derivatives presented under non-current assets
|
||||||||
Swap contracts |
|
|
||||||
Derivatives presented under current liabilities
|
||||||||
Financial power swap
|
(
|
)
|
(
|
) |
||||
Derivatives presented under non-current liabilities
|
||||||||
Financial power swap |
(
|
) |
(
|
)
|
(2) Financial instruments measured at fair value for disclosure purposes only
June 30, 2023
|
|||||||||||||||||||
Fair value
|
|||||||||||||||||||
Carrying
|
Valuation techniques for
|
Inputs used to
|
|||||||||||||||||
amount
|
Level 1
|
Level 2
|
Level 3
|
determining fair value
|
determine fair value
|
||||||||||||||
€ in thousands
|
|||||||||||||||||||
Non-current liabilities:
|
|||||||||||||||||||
Debentures
|
|
|
|
|
|||||||||||||||
Loans from banks and others
(including current maturities) |
|
|
|
|
|
|
|||||||||||||
|
|
|
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Note 7 - Financial Instruments (cont’d)
December 31, 2022
|
|||||||||||||||||||
Fair value
|
|||||||||||||||||||
Carrying
|
Valuation techniques for
|
Inputs used to
|
|||||||||||||||||
amount
|
Level 1
|
Level 2
|
Level 3
|
determining fair value
|
determine fair value
|
||||||||||||||
€ in thousands
|
|||||||||||||||||||
Non-current liabilities:
|
|||||||||||||||||||
Debentures
|
|
|
|
|
|||||||||||||||
Loans from banks and others
(including current maturities) |
|
|
|
|
|
|
|||||||||||||
|
|
|
|
● |
Level 1: quoted prices (unadjusted) in active markets for identical instruments.
|
● |
Level 2: inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.
|
● |
Level 3: inputs that are not based on observable market data (unobservable inputs).
|
June 30, 2023 |
|||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Valuation techniques for
|
|||||||||||||
€ in thousands
|
determining fair value
|
||||||||||||||||
Swap contracts
|
|
|
|
|
|
|
|
||||||||||
Financial power swap
|
|
|
(
|
) |
(
|
) |
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
December 31, 2022 |
|||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Valuation techniques for
|
|||||||||||||
€ in thousands
|
determining fair value
|
||||||||||||||||
Marketable securities
|
|
|
|
|
|
||||||||||||
Swap contracts
|
|
|
|
|
|
|
|
||||||||||
Financial power swap
|
|
|
(
|
) |
(
|
) |
|
Financial assets
|
||||
Financial power swap
|
||||
€ in thousands
|
||||
Balance as at December 31, 2022
|
(
|
)
|
||
Total gains (losses) recognized:
|
||||
In profit or loss
|
||||
Unrealized under financing income and expenses
|
||||
Realized under financing income and expenses
|
||||
In other comprehensive income
|
|
|||
Balance as at June 30, 2023
|
(
|
)
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Office
|
||||||||||||||||||||
Photovoltaic
|
Pumped
|
Biogas
|
furniture and
|
|||||||||||||||||
plants
|
storage
|
installations
|
equipment
|
Total
|
||||||||||||||||
€ in thousands
|
||||||||||||||||||||
Cost
|
||||||||||||||||||||
Balance as at January 1, 2023
|
|
|
|
|
|
|||||||||||||||
Additions
|
|
|
|
|
|
|||||||||||||||
Effect of changes in exchange rates
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||
Balance as at June 30, 2023
|
|
|
|
|
|
|||||||||||||||
Balance as at January 1, 2022
|
|
|
|
|
|
|||||||||||||||
Additions
|
|
|
|
|
|
|||||||||||||||
Effect of changes in exchange rates
|
(
|
) |
(
|
) |
|
|
(
|
) | ||||||||||||
Balance as at December 31, 2022
|
|
|
|
|
|
|||||||||||||||
Depreciation
|
||||||||||||||||||||
Balance as at January 1, 2023
|
|
|
|
|
|
|||||||||||||||
Depreciation for the period
|
|
|
|
|
|
|||||||||||||||
Effect of changes in exchange rates
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Balance as at June 30, 2023
|
|
|
|
|
|
|||||||||||||||
Balance as at January 1, 2022
|
|
|
|
|
|
|||||||||||||||
Depreciation for the year
|
|
|
|
|
|
|||||||||||||||
Effect of changes in exchange rates
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
Balance as at December 31, 2022
|
|
|
|
|
|
|||||||||||||||
Carrying amounts
|
||||||||||||||||||||
As at June 30, 2023
|
|
|
|
|
|
|||||||||||||||
As at December 31, 2022
|
|
|
|
|
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
PV
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||||
Ellomay
|
Bio
|
reportable
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||
Italy
|
Spain
|
Solar
|
Talasol
|
USA |
Israel1
|
Gas
|
Dorad
|
Manara
|
segments
|
Reconciliations
|
consolidated
|
|||||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2023
|
||||||||||||||||||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||||||||||
Revenues
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||||||||||||
Operating expenses
|
|
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||||||||||
Depreciation expenses
|
(
|
) |
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||||||
Gross profit
|
(
|
) |
|
|
|
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||||||||||
Adjusted gross profit |
( |
) |
|
|
|
|
|
1 |
|
|
|
( |
) |
|
||||||||||||||||||||||||||||||||||
Project development costs
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
General and administrative expenses
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Share of profits of equity accounted investee
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Operating profit
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Financing income
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection with derivatives and warrants, net
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Financing expenses
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||||||
Income before taxes on Income
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Segment assets as at June 30, 2023
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
Note 9 - Operating Segments (cont’d)
PV
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||
Ellomay
|
Bio
|
reportable
|
Total
|
|||||||||||||||||||||||||||||||||||||||||
Italy
|
Spain
|
Solar
|
Talasol
|
Israel2
|
Gas
|
Dorad
|
Manara
|
segments
|
Reconciliations
|
consolidated
|
||||||||||||||||||||||||||||||||||
For the six months ended June 30, 2022
|
||||||||||||||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||||||
Revenues
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||||||||
Operating expenses
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||||||
Depreciation expenses
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||||
Gross profit (loss)
|
|
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|
|||||||||||||||||||||||||||||||
Adjusted gross profit (loss) |
|
( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||||
Project development costs
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
General and administrative expenses
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
Share of profits of equity
|
||||||||||||||||||||||||||||||||||||||||||||
accounted investee
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
Operating profit
|
|
|||||||||||||||||||||||||||||||||||||||||||
Financing income
|
|
|||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection
|
||||||||||||||||||||||||||||||||||||||||||||
with derivatives and warrants, net
|
|
|||||||||||||||||||||||||||||||||||||||||||
Financing expenses
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
Income before taxes on Income
|
|
|||||||||||||||||||||||||||||||||||||||||||
Segment assets as at
|
||||||||||||||||||||||||||||||||||||||||||||
June 30, 2022
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
* Segment presentation for prior periods was adjusted to reflect revenues and operating expenses for the Talmei Yosef PV Plant under IFRIC 12 and not under the fixed asset model and to include the adjusted gross profit of such segment, to align the presentation with the presentation of the segments for the period ended June 30, 2023.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
PV
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||
Ellomay
|
Bio
|
reportable
|
Total
|
|||||||||||||||||||||||||||||||||||||||||
Italy
|
Spain
|
Solar
|
Talasol
|
Israel3
|
Gas
|
Dorad
|
Manara
|
segments
|
Reconciliations
|
consolidated
|
||||||||||||||||||||||||||||||||||
For the year ended December 31, 2022
|
||||||||||||||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||||||
Revenues
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||||||||||||||
Operating expenses
|
|
(
|
)
|
( |
) |
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||||||
Depreciation expenses
|
|
(
|
)
|
( |
) |
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||||||
Gross profit (loss)
|
|
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|
|||||||||||||||||||||||||||||||
Adjusted gross profit (loss) |
|
|
|
|
( |
) |
|
|
( |
) |
|
|||||||||||||||||||||||||||||||||
Project development costs
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
General and administrative expenses
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
Share of loss of equity accounted investee
|
|
|||||||||||||||||||||||||||||||||||||||||||
Operating profit
|
|
|||||||||||||||||||||||||||||||||||||||||||
Financing income
|
|
|||||||||||||||||||||||||||||||||||||||||||
Financing expenses in connection with derivatives and warrants, net
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Financing expenses, net
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||||||
Loss before taxes on income
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Segment assets as at December 31, 2022 |
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
1. | Material lease agreements entered into during the period |
2. | Right-of-use assets |
Gelderland
|
Italy
|
Spain
|
Talasol
|
Talmei
Yosef
|
Pumped storage
|
Total
|
||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||
Cost
|
||||||||||||||||||||||||||||
Balance as at January 1, 2023
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Additions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Depreciation for the period
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||
Other
|
|
(
|
)
|
|
|
|
|
(
|
) | |||||||||||||||||||
Effect of changes in exchange rates
|
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||
Balance as at June 30, 2023
|
|
|
|
|
|
|
|
3. | Lease liability |
June 30, 2023
|
||||
€ in thousands
|
||||
Less than one year
|
|
|||
One to five years
|
|
|||
More than five years
|
|
|||
Total
|
|
|||
Current maturities of lease liability
|
|
|||
Long-term lease liability
|
|
F - 25
Name
|
Installed/ production Capacity1
|
Location
|
Type of Plant
|
Connection to Grid
|
Fixed Tariff
|
Revenue in the six months ended June 30, 2022 (in thousands)2
|
Revenue in the six months ended June 30, 2023 (in thousands)2
|
“Rinconada II”
|
2,275 kWp
|
Municipality of Córdoba, Andalusia, Spain
|
PV – Fixed panels
|
July 2010
|
N/A
|
€601
|
€441
|
“Rodríguez I”
|
1,675 kWp
|
Province of Murcia, Spain
|
PV – Fixed panels
|
November 2011
|
N/A
|
€442
|
€308
|
“Rodríguez II”
|
2,691 kWp
|
Province of Murcia, Spain
|
PV – Fixed panels
|
November 2011
|
N/A
|
€716
|
€509
|
“Fuente Librilla”
|
1,248 kWp
|
Province of Murcia, Spain
|
PV – Fixed panels
|
June 2011
|
N/A
|
€322
|
€205
|
“Talmei Yosef”
|
9,400 kWp
|
Talmei Yosef, Israel
|
PV – Fixed panels
|
November 2013
|
1.01853 (NIS/kWh)
|
€5564
|
€4594
|
“Talasol”
|
300,000 kWp
|
Talaván, Cáceres, Spain
|
PV – Fixed panels
|
December 2020
|
N/A
|
€20,402
|
€12,666
|
“Ellomay Solar”
|
28,000 kWp
|
Talaván, Cáceres, Spain
|
PV – Fixed panels
|
June 2022
|
N/A
|
€327
|
€2,080
|
“Groen Gas Goor”
|
3 million Nm3 per year
|
Goor, the Netherlands
|
Biogas
|
November 2017
|
N/A
|
€1,354
|
€2,366
|
“Goren Gas Oude-Tonge”
|
3.8 million Nm3 per year
|
Oude-Tonge, the Netherlands
|
Biogas
|
June 2018
|
N/A
|
€1,417
|
€2,624
|
“Groen Gas Gelderland”
|
7.5 million Nm3 per year6
|
Gelderland, the Netherlands
|
Biogas
|
April 2017
|
N/A
|
€3,059
|
€3,800
|
Six months ended June 30,
|
June 30, 2023 vs. June 30, 2022 Change
|
|||||||||||||||
(Euro in thousands)
|
2023
|
2022
|
€ |
%
|
||||||||||||
Spanish PV segment
|
1,463
|
2,081
|
(618
|
)
|
(30
|
)%
|
||||||||||
Ellomay Solar PV segment
|
2,080
|
327
|
1,753
|
536
|
%
|
|||||||||||
Talasol PV segment
|
12,666
|
20,402
|
(7,736
|
)
|
(38
|
)%
|
||||||||||
Israeli PV segment
|
459
|
556
|
(97
|
)
|
(17
|
)%
|
||||||||||
Netherlands Biogas segment
|
8,790
|
5,830
|
2,960
|
51
|
%
|
|||||||||||
Dorad segment
|
30,305
|
26,756
|
3,549
|
13
|
%
|
Six months ended June 30,
|
June 30, 2023 vs. June 30, 2022 Change
|
|||||||||||||||
(Euro in thousands)
|
2023
|
2022
|
€ |
%
|
||||||||||||
Spanish PV segment
|
264
|
100
|
164
|
164
|
%
|
|||||||||||
Ellomay Solar PV segment
|
882
|
191
|
691
|
362
|
%
|
|||||||||||
Talasol PV segment
|
3,125
|
7,088
|
(3,963
|
)
|
(56
|
)%
|
||||||||||
Israeli PV segment
|
183
|
214
|
(31
|
)
|
(14
|
)%
|
||||||||||
Netherlands Biogas segment
|
7,574
|
5,539
|
2,035
|
37
|
%
|
|||||||||||
Dorad segment
|
22,588
|
20,769
|
1,819
|
9
|
%
|
For the six months ended June 30
|
||||||||
2023
|
2022
|
|||||||
€ in thousands
|
||||||||
Interest income and consumer price index in Israel in connection to concession project
|
792
|
1,689
|
||||||
Interest income
|
1,359
|
122
|
||||||
Gain from exchange rate differences, net
|
6,870
|
2,628
|
||||||
Change in fair value of derivatives, net
|
(476
|
)
|
338
|
|||||
Debentures interest and related expenses
|
(1,840
|
)
|
(1,343
|
)
|
||||
Consumer price index in Israel for loan
|
(364
|
)
|
(551
|
)
|
||||
Interest and commissions related to projects finance
|
(3,280
|
)
|
(3,206
|
)
|
||||
Amortization of capitalized expenses related to projects finance
|
(138
|
)
|
(132
|
)
|
||||
Interest on minority shareholder loan
|
(933
|
)
|
(892
|
)
|
||||
Bank charges and other commissions
|
(227
|
)
|
(656
|
)
|
||||
Interest on lease liability
|
(207
|
)
|
(178
|
)
|
||||
Total financing income (expenses), net
|
1,556
|
(2,181
|
)
|
Year ended December 31,
|
Six months ended June 30,
|
|||||||||||||||
2022
|
2021
|
2023
|
2022
|
|||||||||||||
Appreciation (Devaluation) of the euro against the NIS
|
6.6
|
%
|
(10.8
|
)%
|
7.1
|
%
|
3.3
|
%
|
Six months ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(euro in thousands)
|
||||||||
Net cash provided by operating activities
|
5,271
|
8,017
|
||||||
Net cash used in investing activities
|
(25,840
|
)
|
(3,249
|
)
|
||||
Net cash provided by financing activities
|
51,459
|
17,082
|
||||||
Exchange differences on balances of cash and cash equivalents
|
(3,478
|
)
|
(3,128
|
)
|
||||
Increase in cash and cash equivalents
|
27,412
|
18,722
|
||||||
Cash and cash equivalents at beginning of period
|
46,458
|
41,229
|
||||||
Cash and cash equivalents at end of period
|
73,870
|
59,951
|
_6BX?6SU__A((_P"\*!X@C_O"O(/[>D_O?K3EUY_[Q_.B
MX?6SUQO$,8_B%7;'5EN6P"#7B4_B!P/O?K76>#-4>YF4%N].XZ>* 4'EJ
MV(?$48QEA^=6FK'5&M<[^.3=4U8.D:DMT!@YK>'2F=,7=!2$X%+5>XF"1DT#
M&27 5L9IK7("9S7,:AK:0S$%A523Q'&8C\P_.E M3'5_>L."PE"]ZF-E+[T"-;^U_>C^V/>LC[%+[T&RE]Z -J+5MS8S6M;7
M6_'-:>"(-URN1WKW33H D*\=J<37"4TU
#7K'BG2]TCOMKRW44\J::3S2AJ"!